Operating income · Fiscal year 2025
| 1 | Johnson & JohnsonJNJ | $32.6B |
|---|---|---|
| 2 | Eli LillyLLY | $25.7B |
| 3 | MerckMRK | $21.1B |
| 4 | Novo Nordisk A SNVO | $19.3B |
| 5 | UnitedHealth GroupUNH | $19.0B |
| 6 | AbbVieABBV | $15.1B |
| 7 | AstraZenecaAZN | $13.7B |
| 8 | GSKGSK | $10.5B |
| 9 | Gilead SciencesGILD | $10.0B |
| 10 | HCA HealthcareHCA | $9.8B |